GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Long-Term Debt

ENCell Co (XKRX:456070) Long-Term Debt : ₩550 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Long-Term Debt?

ENCell Co's Long-Term Debt for the quarter that ended in Dec. 2024 was ₩550 Mil.

ENCell Co's quarterly Long-Term Debt declined from Mar. 2024 (₩775 Mil) to Sep. 2024 (₩625 Mil) and declined from Sep. 2024 (₩625 Mil) to Dec. 2024 (₩550 Mil).

ENCell Co's annual Long-Term Debt declined from Dec. 2022 (₩1,150 Mil) to Dec. 2023 (₩850 Mil) and declined from Dec. 2023 (₩850 Mil) to Dec. 2024 (₩550 Mil).

ENCell Co Long-Term Debt Historical Data

The historical data trend for ENCell Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Long-Term Debt Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
5,200.00 1,450.00 1,150.00 850.00 550.00

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only - 850.00 775.00 625.00 550.00

ENCell Co  (XKRX:456070) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ENCell Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ENCell Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Long-Term Debt
Comparable Companies
XKRX:060590 XKRX:083790 XKRX:011000 XKRX:353810 XKRX:127120 XKRX:376270 XKRX:086890 XKRX:203400 XKRX:278650 XKRX:234690 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
Website
http://www.encellinc.com
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines